Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This artificial peptide resembles the actions of naturally present GLP-1, a https://roryfvsk198334.theideasblog.com/39660327/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes